Quick Answer
PLIANT THERAPEUTICS, INC. reported Total Assets of $225.23 million for the year ending 2025.
- PLIANT THERAPEUTICS, INC. showed a decrease of -43.3% in Total Assets from 2024 to 2025.
- This data is from PLIANT THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $328.80 million | Q3 2020: $312.32 million | Q1 2021: $275.25 million | Q2 2021: $255.72 million | Q3 2021: $234.12 million | Q1 2022: $197.02 million | Q2 2022: $184.62 million | Q3 2022: $377.18 million | Q1 2023: $597.88 million | Q2 2023: $574.89 million | Q3 2023: $540.46 million | Q1 2024: $521.61 million | Q2 2024: $483.73 million | Q3 2024: $445.67 million | Q1 2025: $344.77 million | Q2 2025: $299.82 million | Q3 2025: $276.60 million.
- Over the full 7 years of available data (2019 to 2025), PLIANT THERAPEUTICS, INC.'s Total Assets has grown by 89.2%.
- Historical annual values: Fiscal year 2025: $225.23 million | Fiscal year 2024: $396.95 million | Fiscal year 2023: $512.15 million | Fiscal year 2022: $350.61 million | Fiscal year 2021: $221.22 million | Fiscal year 2020: $295.53 million | Fiscal year 2019: $119.06 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: